DK630589A - 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION - Google Patents

2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION Download PDF

Info

Publication number
DK630589A
DK630589A DK630589A DK630589A DK630589A DK 630589 A DK630589 A DK 630589A DK 630589 A DK630589 A DK 630589A DK 630589 A DK630589 A DK 630589A DK 630589 A DK630589 A DK 630589A
Authority
DK
Denmark
Prior art keywords
dideoxypurinnucleosid
purine nucleoside
inhibitor composition
nucleoside phosphorylase
phosphorylase inhibitor
Prior art date
Application number
DK630589A
Other languages
Danish (da)
Other versions
DK630589D0 (en
Inventor
Mark D Erion
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK630589D0 publication Critical patent/DK630589D0/en
Publication of DK630589A publication Critical patent/DK630589A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK630589A 1988-12-14 1989-12-13 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION DK630589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28415388A 1988-12-14 1988-12-14
US31535489A 1989-02-24 1989-02-24

Publications (2)

Publication Number Publication Date
DK630589D0 DK630589D0 (en) 1989-12-13
DK630589A true DK630589A (en) 1990-06-15

Family

ID=26962435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK630589A DK630589A (en) 1988-12-14 1989-12-13 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION

Country Status (10)

Country Link
EP (1) EP0374096B1 (en)
JP (1) JPH02204414A (en)
KR (1) KR900009083A (en)
AU (1) AU628113B2 (en)
CA (1) CA2005205A1 (en)
DE (1) DE58902899D1 (en)
DK (1) DK630589A (en)
IE (1) IE893991L (en)
IL (1) IL92587A (en)
NZ (1) NZ231718A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
ES2106732T3 (en) * 1989-02-27 1997-11-16 Biocryst Pharm Inc DESAZAGUANINAS SUBSTITUTED IN 9 AND NOT SUBSTITUTED IN 8.
JP2619710B2 (en) * 1989-02-27 1997-06-11 日本製紙 株式会社 Method for producing 2 ', 3'-dideoxypurine nucleosides
ES2085446T3 (en) * 1990-07-04 1996-06-01 Merrell Pharma Inc DERIVATIVES OF 9-PURINYL PHOSPHONIC ACID.
AU1787492A (en) * 1991-05-16 1992-12-30 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
US5494912A (en) * 1991-06-26 1996-02-27 Merrell Pharmaceuticals Inc. 9-purinyl phosphonic acid derivitives for treating gout
CZ27399A3 (en) * 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituted nitrogen heterocyclic derivatives process of their preparation, the derivatives employed as medicaments, pharmaceutical composition and a compound pharmaceutical preparation in which these derivatives are comprised as well as use of these derivatives for preparing medicaments
US7557113B2 (en) 2003-08-26 2009-07-07 Teijin Pharma Limited Substituted pyrrolo[3,2-d]pyrimidine derivatives
CA2536887C (en) * 2003-08-26 2012-03-06 Teijin Pharma Limited Pyrrolopyrimidinone derivatives
DE102006017600A1 (en) * 2006-02-09 2007-08-16 Friedel, Ruthard, Dr. Use of nucleoside analogues such as purine derivatives, as medicines against viruses and cytostatic against cancer, where the nucleoside analogue has a donor group, acceptor group, and pairs only with natural base thymine
EP3010340A4 (en) * 2013-06-22 2017-08-02 Nitor Therapeutics Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
US10729711B2 (en) 2016-08-30 2020-08-04 University of Pittsburgh—of the Commonwealth System of Higher Education Methods for treatment using small molecule potassium-sparing diuretics and natriuretics
GB201820098D0 (en) * 2018-12-10 2019-01-23 Cambridge Entpr Ltd Methods of cancer treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126220A (en) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc Nucleic acid component composition
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases

Also Published As

Publication number Publication date
KR900009083A (en) 1990-07-02
EP0374096A1 (en) 1990-06-20
JPH02204414A (en) 1990-08-14
IE893991L (en) 1990-06-14
NZ231718A (en) 1992-02-25
IL92587A (en) 1994-04-12
IL92587A0 (en) 1990-08-31
CA2005205A1 (en) 1990-06-14
AU4607489A (en) 1990-06-21
DK630589D0 (en) 1989-12-13
DE58902899D1 (en) 1993-01-14
EP0374096B1 (en) 1992-12-02
AU628113B2 (en) 1992-09-10

Similar Documents

Publication Publication Date Title
PT526253E (en) ANALOGS OF NUCLEOSIDE 1,3-OXATIOLANE
LV5781B4 (en) Healing Nucleoside
DK23489A (en) nucleoside
KR900007991A (en) Primer composition
DK375989A (en) purine derivatives
DK630589A (en) 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION
DK564088D0 (en) nucleoside
NO921679L (en) PURIN NUCLEOSIDE PHOSPHORYLASE INHIBITORS
NZ235534A (en) 3'-azido-2',3'-dideoxy purine derivatives
FI932868A (en) 2'-DEOXY-2'2'-DIFLUOR (2,6,8-SUBSTITUTES) PURINNUKLEOSIDER MED VIRUS-OCH CANCERHAEMMANDE ACTIVITIES, AS WELL
EP0365849A3 (en) Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives
OA09697A (en) Nucleoside derivatives
DE68914750T2 (en) Therapeutic nucleosides.
DK626989A (en) adenosine
DK95791A (en) nucleoside analogues
LTIP1982A (en) 9-deazahypoxantines, useful as purine nucleoside phosphorylase inhibitors
NO891835D0 (en) PRODRUG FORMS OF 2 ', 3'-DIDEHYDRO-2', 3'-DIDEOXY NUCLEOSIDES.
DK339189D0 (en) purine derivatives
DE69002365T2 (en) Antiviral composition.
ZA899510B (en) 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition
ATE104675T1 (en) THERAPEUTIC NUCLEOSIDES.
NO921776D0 (en) Nucleoside derivative
IE891764L (en) Nucleoside compositions
GB8925039D0 (en) Nucleoside derivatives
GB8925037D0 (en) Nucleoside derivatives

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment